| NDC Code | 70771-1622-4 |
|---|
| Package Description | 10 BLISTER PACK in 1 CARTON (70771-1622-4) / 10 TABLET, FILM COATED in 1 BLISTER PACK (70771-1622-2) |
|---|
| Product NDC | 70771-1622 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Emtricitabine And Tenofovir Disoproxil Fumarate |
|---|
| Non-Proprietary Name | Emtricitabine And Tenofovir Disoproxil Fumarate |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20210701 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA212689 |
|---|
| Manufacturer | Zydus Lifesciences Limited |
|---|
| Substance Name | EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE |
|---|
| Strength | 167; 250 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS], Nucleosides [CS] |
|---|